ArticleJournal of molecular endocrinology2010
Rosiglitazone activation of PPARgamma suppresses fractalkine signaling.
Yihong Wan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled ittrialcites it